Strand V - Search Results

1

American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon LS, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M. Felson DT, et al. Among authors: strand v. Ann Rheum Dis. 2011 Mar;70(3):404-13. doi: 10.1136/ard.2011.149765. Ann Rheum Dis. 2011. PMID: 21292833 Free article.

2

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, et al. Felson DT, et al. Among authors: strand v. Arthritis Rheum. 1995 Jun;38(6):727-35. doi: 10.1002/art.1780380602. Arthritis Rheum. 1995. PMID: 7779114

3

Biologic agents in autoimmune diseases.

Keystone EC, Strand V. Keystone EC, et al. Among authors: strand v. J Rheumatol. 1996 Apr;23(4):743-6. J Rheumatol. 1996. PMID: 8730137 No abstract available.

4

Biologic agents for the treatment of rheumatoid arthritis.

Strand V, Keystone E, Breedveld F. Strand V, et al. Rheum Dis Clin North Am. 1996 Feb;22(1):117-32. doi: 10.1016/s0889-857x(05)70265-9. Rheum Dis Clin North Am. 1996. PMID: 8907068 Free article. Review.

5

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.

Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. Bellamy N, et al. Among authors: strand v. J Rheumatol. 1997 Apr;24(4):799-802. J Rheumatol. 1997. PMID: 9101522 Review.

6

Clinical response to nonsteroidal antiinflammatory drugs.

Simon LS, Strand V. Simon LS, et al. Among authors: strand v. Arthritis Rheum. 1997 Nov;40(11):1940-3. doi: 10.1002/art.1780401104. Arthritis Rheum. 1997. PMID: 9365081 No abstract available.

7

Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspective.

Wallis WJ, Furst DE, Strand V, Keystone E. Wallis WJ, et al. Among authors: strand v. Rheum Dis Clin North Am. 1998 Aug;24(3):537-65. doi: 10.1016/s0889-857x(05)70025-9. Rheum Dis Clin North Am. 1998. PMID: 9710886 Review.

8

How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.

Maetzel A, Bombardier C, Strand V, Tugwell P, Wells G. Maetzel A, et al. Among authors: strand v. J Rheumatol. 1998 Dec;25(12):2331-8. J Rheumatol. 1998. PMID: 9858426

9

Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.

Gazarian M, Tugwell P, Boers M, Bombardier C, Brooks P, Day R, Strand V, Wells G. Gazarian M, et al. Among authors: strand v. J Rheumatol. 1999 Jan;26(1):207-9. J Rheumatol. 1999. PMID: 9918265

10

Outcome measures to be used in clinical trials in systemic lupus erythematosus.

Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Strand V, et al. J Rheumatol. 1999 Feb;26(2):490-7. J Rheumatol. 1999. PMID: 9972993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

534 results

Search Page

Filters